Description
A leukotriene; metabolite of EPA formed through 5-LO pathway; increases contraction of bullfrog lung strips ex vivo in a concentration-dependent manner; reduces tumor volume in mice injected with Tm1 murine melanoma cells (100 nM); elicits chemokinesis and lysosomal enzyme release from PMNLs; induces platelet aggregation
Formal name: 5S,12R-dihydroxy-6Z,8E,10E,14Z,17Z-eicosapentaenoic acid
Synonyms: LTB5
Molecular weight: 334.5
CAS: 80445-66-5
Purity: ≥98%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Leukotrienes||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cancer||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Leukotrienes||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Lipoxygenase Pathways